Enhance the outcomes for lung cancer patients through integrative data-driven approaches that deliver precise diagnosis and personalized treatment.
Build a learning health system that delivers a comprehensive clinical and molecular understanding of our lung cancer patients to improve their pathways to diagnosis, enable guideline-driven personalized care, and increase access to translational research.
Lung Cancer Research and Precision Medicine
Questions we're asking that inform us on how to best care for patients include:
Can we improve outcomes by integrating molecular, pathological, and clinical data to match patients with the best therapies?
Novel Predictive Biomarkers
Can we discover novel clinical and biological predictors of response to therapies to tailor treatment?
Adaptive Treatment Strategies
Can we identify subsets of patients where new therapeutic strategies, beyond existing guidelines, are needed?
The Lung Cancer Program is dedicated to advancing the care of patients with thoracic cancer by recruiting patients to clinical trials. Beyond providing access to promising new treatments, clinical trials drive the future of lung cancer care through evaluation of safety, efficacy, and translational research.
Patient CarePatient Care for Lung Cancer
Our comprehensive Lung Cancer Program includes multi-disciplinary experts at multiple clinical sites of our National Cancer Institute-designated Comprehensive Cancer Center.